213 related articles for article (PubMed ID: 31310926)
21. Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis.
Liu B; Ai P; Zheng D; Jiang Y; Liu X; Pan S; Wang H
J Neuroimmunol; 2018 Feb; 315():40-44. PubMed ID: 29306404
[TBL] [Abstract][Full Text] [Related]
22. Elevated cerebrospinal fluid YKL-40 levels in patients with anti-gamma-aminobutyric- acid-B receptor encephalitis.
Li J; Wang Y; Xia R; Zhao X; Li L; Wang S
J Neuroimmunol; 2023 Aug; 381():578119. PubMed ID: 37301084
[TBL] [Abstract][Full Text] [Related]
23. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
[TBL] [Abstract][Full Text] [Related]
24. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
25. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
Ai P; Zhang X; Xie Z; Liu G; Liu X; Pan S; Wang H
Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630
[TBL] [Abstract][Full Text] [Related]
26. Japanese encephalitis-induced anti-N-methyl-d-aspartate receptor encephalitis: A hospital-based prospective study.
Ma J; Han W; Jiang L
Brain Dev; 2020 Feb; 42(2):179-184. PubMed ID: 31563418
[TBL] [Abstract][Full Text] [Related]
27. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
[TBL] [Abstract][Full Text] [Related]
28. Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome.
Deng B; Liu XN; Li X; Zhang X; Quan C; Chen XJ
J Neuroimmunol; 2017 Apr; 305():84-91. PubMed ID: 28284352
[TBL] [Abstract][Full Text] [Related]
29. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
Liba Z; Kayserova J; Elisak M; Marusic P; Nohejlova H; Hanzalova J; Komarek V; Sediva A
J Neuroinflammation; 2016 Mar; 13(1):55. PubMed ID: 26941012
[TBL] [Abstract][Full Text] [Related]
30. Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis.
Chen J; Ding Y; Zheng D; Wang Z; Pan S; Ji T; Shen HY; Wang H
Front Neurol; 2018; 9():727. PubMed ID: 30369903
[No Abstract] [Full Text] [Related]
31. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
[TBL] [Abstract][Full Text] [Related]
32. Brain magnetic resonance imaging as predictors in pediatric anti-N-methyl-D-aspartate receptor encephalitis.
Hou C; Li X; Zeng Y; Gao Y; Wu W; Zhu H; Zhang Y; Wu W; Tian Y; Zheng K; Chen L; Peng B; Chen WX
Mult Scler Relat Disord; 2024 Feb; 82():105061. PubMed ID: 38134605
[TBL] [Abstract][Full Text] [Related]
33. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
34. Anti-N-methyl-D-aspartate receptor encephalitis: a prospective study focused on cerebrospinal fluid and clinical symptoms.
Wu S; Li H; Lian Y; Chen Y; Zheng Y; Wang C; Zhang Q; Huang Z; Mao Z; Pang K
Neurol Sci; 2020 Nov; 41(11):3255-3263. PubMed ID: 32399951
[TBL] [Abstract][Full Text] [Related]
35. Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
Kothur K; Wienholt L; Mohammad SS; Tantsis EM; Pillai S; Britton PN; Jones CA; Angiti RR; Barnes EH; Schlub T; Bandodkar S; Brilot F; Dale RC
PLoS One; 2016; 11(8):e0161656. PubMed ID: 27575749
[TBL] [Abstract][Full Text] [Related]
36. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
[TBL] [Abstract][Full Text] [Related]
37. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit.
Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X
Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725
[TBL] [Abstract][Full Text] [Related]
38. Elevated Soluble Fas and FasL in Cerebrospinal Fluid and Serum of Patients With Anti-N-methyl-D-aspartate Receptor Encephalitis.
Ding YW; Pan SY; Xie W; Shen HY; Wang HH
Front Neurol; 2018; 9():904. PubMed ID: 30410466
[No Abstract] [Full Text] [Related]
39. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
40. Low serum vitamin D levels and anti-N-methyl-d-aspartate receptor encephalitis: A case-control study.
Shu Y; Su Q; Liao S; Lu T; Li R; Sun X; Qiu W; Yang Y; Hu X; Lu Z
Neurochem Int; 2017 Jan; 102():89-94. PubMed ID: 27836631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
